Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients

BACKGROUND: Prolyl 4-hydroxylase subunit beta (P4HB) has been reported as a suppressor in ferroptosis. However, no known empirical research has focused on exploring relationships between P4HB and prostate cancer (PCa). In this research, we initially examine the function of P4HB in PCa by thorough an...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Dechao, Li, Li, Li, Dengxiong, Wu, Ruicheng, Zhu, Weizhen, Wang, Jie, Ye, Luxia, Han, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362756/
https://www.ncbi.nlm.nih.gov/pubmed/37480146
http://dx.doi.org/10.1186/s40001-023-01215-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362756/
https://www.ncbi.nlm.nih.gov/pubmed/37480146
http://dx.doi.org/10.1186/s40001-023-01215-2

Ejemplares similares